GlassScriptPhysician profile
Sean T George
NPI 1427067990
$8,685.67
in general payments reported to CMS, 2019-2025
19 companies · $1,520 in 2025
The $1,520 reported for 2025 was more than what 78% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,115 · 2020: $905 · 2021: $601 · 2022: $1,045 · 2023: $1,116 · 2024: $1,383 · 2025: $1,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,019.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,688.40 | 2019-2025 | Advantage System, Capio Rp, Axonics |
| Gynesonics, INC. | $1,325.12 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $1,011.68 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $820.22 | 2023-2025 | Myfembree |
| Medtronic, INC. | $674.04 | 2021-2025 | Truclear, Signia, Interstim |
| Axonics, INC. | $430.18 | 2022-2024 | Bulkamid, Axonics |
| Stryker Corporation | $296.65 | 2019-2021 | |
| Myovant Sciences INC. | $293.53 | 2022 | |
| Coloplast Corp | $285.54 | 2019 | |
| Astellas Pharma US INC | $270.06 | 2019-2021 | |
| Acessa Health INC. | $137.88 | 2019-2020 | |
| Bluewind Medical | $132.28 | 2024 | Revi |
| Intuitive Surgical, INC. | $90.08 | 2022 | |
| Minerva Surgical, INC | $69.58 | 2019-2023 | |
| Covidien LP | $52.73 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $47.04 | 2024-2025 | |
| Pfizer INC. | $32.39 | 2019 | |
| Mission Pharmacal Company | $17.07 | 2019 | |
| Dysis Medical, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.